GE HealthCare (NASDAQ:GEHC) lost ~8% premarket Wednesday after the health tech company lowered its full-year revenue guidance, citing headwinds in China. Notwithstanding pressures in its Chinese ...

GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.

The company lowered its guidance for revenue growth for the full fiscal year, citing headwinds in China among other reasons. GE HealthCare (GEHC) shares rose over 4% in early trading Wednesday ...

GE HealthCare has announced a leadership transition for its China operations, with Will Song to succeed Yihao Zhang as new president and CEO. Song is set to join the company on 1 April 2025 ...

Goldman Sachs upgraded GE Healthcare to Buy, raising its price target from $85 to $100. Analysts expect China sales to recover to 2023 levels by 2026, two years earlier than previously forecast.

Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region ...